Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1

Stanislaw R Burzynski,
Gregory S Burzynski,
Tomasz J Janicki,
Samuel W Beenken
  10.33425/2692-7918.1036 Published: 10 Sep, 2022

Burzynski S, Burzynski G, Janicki T, Beenken S. Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1 Neurol Neurosci. 2022; 3(3):1-9